Laurie Toich, Assistant Editor

Women in Specialty Pharmacy Lunch brings together leaders from various aspects of the specialty landscape.

Payer requirements for outcomes data are becoming more stringent.

Testing and treatment programs should focus on populations driving new cases of hepatitis C virus.

Cardiovascular risks soar after stopping low-dose aspirin therapy.

Eliminating barriers to non-drug and non-opioid pain management would reduce the effects of the opioid epidemic.

Nearly 80% of Americans said they would follow their pharmacist on social media.

Gadolinium-containing imaging agent could improve breast cancer survival.

Top news of the day from across the healthcare landscape.

Peripheral resistance was a major factor in high systolic blood pressure in men but not in women.

Many patients with type 1 and type 2 diabetes are unable to control blood glucose levels after meals.

Maintaining a healthy weight may be an important factor in preventing high blood pressure.

The approval of tisagenlecleucel (Kymriah) brings in a new era of drug reimbursement.

Macrophages promote healing of the intestinal epithelial barrier and can reduce inflammation in patients with inflammatory bowel disease.

Top news of the day from across the healthcare landscape.

Rebecca Shanahan, NASP president and CEO of Avella Specialty Pharmacy, announced the Distinguished Service Award and the Specialty Pharmacy of the Year Award.

The Improving Transparency and Accuracy in Medicare Part D Spending Act seeks to halt direct and indirect remuneration fees on Part D claims without any defect, impropriety, or fraud.

The Improving Transparency and Accuracy in Medicare Part D Spending Act would end direct and indirect remuneration fees.

Inhibiting neuroligin-3 in mice delayed the proliferation of high-grade glioma.

Prescribing beta blockers after a heart attack may be unnecessary.

Drinking at least 1 cup of coffee per day could reduce the risk of all-cause mortality by 51%.

Top news of the day from across the healthcare landscape.

The agreement requires Amgen to pay royalties to AbbVie for sales of the biosimilar, according to a press release.

Reports from an investment bank suggest Amazon is looking to collaborate with a PBM.

Direct and indirect remuneration fees have inflicted harm on specialty pharmacies and the patients they treat.

CVS to limit opioid prescriptions to 7 days for certain conditions.

Higher-income individuals living in low-income areas had lower cardiovascular risks than those with lower incomes.

Agreement clears path to launch of Humira biosimilar.

AbbVie grants commercialization rights to Amjevita.

Top news of the day from across the healthcare landscape.

High costs of prescription drugs outweigh the concern of quality of care received in some states.